Park Ha Biological Technology Co., Ltd. - Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Park Ha Biological Technology Co., Ltd., a foreign private issuer, on August 26, 2025. The filing covers the month of August 2025 and includes unaudited consolidated financial statements and an operating review for the six months ended April 30, 2025, compared to the same period in 2024.
Key Financial Metrics
The provided text contains only the cover page and exhibit index of the filing. It does not include the actual financial statements or the operating review text. Consequently, specific values for revenue, profit, cash flow, margins, debt, and liquidity are not present in the source data.
Material Changes
The filing text does not provide a clear value or description of material changes versus the prior comparable period. This information is contained within Exhibit 99.1 and Exhibit 99.2, which are referenced but not included in the input text.
Guidance, Outlook, and Risks
Management commentary, guidance, outlook, risks, contingencies, and unusual items are not detailed in the provided text. These disclosures are expected to be found in the "Operating and Financial Review and Prospects" (Exhibit 99.1) referenced in the exhibit index.
Investor Verification Checklist
- Verify the specific revenue and net income figures for the six months ended April 30, 2025, by reviewing Exhibit 99.2.
- Confirm the company's cash position and liquidity status as detailed in the unaudited consolidated financial statements.
- Review the "Operating and Financial Review and Prospects" (Exhibit 99.1) for management's discussion of risks and future outlook.
- Check for any material changes in operations or financial condition compared to the six months ended April 30, 2024.